Sladjana Andrejević

987 total citations
40 papers, 618 citations indexed

About

Sladjana Andrejević is a scholar working on Rheumatology, Immunology and Genetics. According to data from OpenAlex, Sladjana Andrejević has authored 40 papers receiving a total of 618 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Rheumatology, 13 papers in Immunology and 7 papers in Genetics. Recurrent topics in Sladjana Andrejević's work include Systemic Lupus Erythematosus Research (14 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (5 papers). Sladjana Andrejević is often cited by papers focused on Systemic Lupus Erythematosus Research (14 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (5 papers). Sladjana Andrejević collaborates with scholars based in Serbia, Czechia and Croatia. Sladjana Andrejević's co-authors include Branka Bonači‐Nikolić, Miloš Nikolić, Ivica Jeremić, Svetlana Zorić, Branislava Ivanović, Biljana Stojimirović, Jelena Drulović, Predrag Miljić, Mitja Košnik and Peter Korošec and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Sladjana Andrejević

38 papers receiving 596 citations

Peers

Sladjana Andrejević
Sladjana Andrejević
Citations per year, relative to Sladjana Andrejević Sladjana Andrejević (= 1×) peers Patricia Moya

Countries citing papers authored by Sladjana Andrejević

Since Specialization
Citations

This map shows the geographic impact of Sladjana Andrejević's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sladjana Andrejević with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sladjana Andrejević more than expected).

Fields of papers citing papers by Sladjana Andrejević

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sladjana Andrejević. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sladjana Andrejević. The network helps show where Sladjana Andrejević may publish in the future.

Co-authorship network of co-authors of Sladjana Andrejević

This figure shows the co-authorship network connecting the top 25 collaborators of Sladjana Andrejević. A scholar is included among the top collaborators of Sladjana Andrejević based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sladjana Andrejević. Sladjana Andrejević is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Šelb, Julij, Mitja Košnik, Mihaela Zidarn, et al.. (2024). The CC2D2B is a novel genetic modifier of the clinical phenotype in patients with hereditary angioedema due to C1 inhibitor deficiency. Gene. 919. 148496–148496. 1 indexed citations
2.
Pekmezović, Tatjana, Nikola Veselinović, Evica Dinčić, et al.. (2024). Aquaporin4-IgG seropositivity significantly increases the risk of comorbid autoimmune diseases in NMOSD patients: population-based registry data. Journal of Neurology. 271(12). 7525–7536. 4 indexed citations
3.
Valerieva, Anna, Maria Staevska, Miloš Jeseňák, et al.. (2019). Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema. The Journal of Allergy and Clinical Immunology In Practice. 8(2). 799–802. 22 indexed citations
4.
Matić, Ivana Z., et al.. (2018). Celiac disease-specific and inflammatory bowel disease-related antibodies in patients with recurrent aphthous stomatitis. Immunobiology. 224(1). 75–79. 12 indexed citations
5.
Riedl, Marc A., Vesna Grivcheva‐Panovska, Dumitru Moldovan, et al.. (2017). Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trial. The Lancet. 390(10102). 1595–1602. 48 indexed citations
6.
Andrejević, Sladjana, et al.. (2016). Coexistence of Autoantibodies against the Golgi Complex and Ro52 Antigen in a Patient with Nonspecific Interstitial Pneumonia. Internal Medicine. 55(3). 273–278. 3 indexed citations
7.
Andrejević, Sladjana, Peter Korošec, Mira Šilar, et al.. (2015). Hereditary Angioedema Due to C1 Inhibitor Deficiency in Serbia: Two Novel Mutations and Evidence of Genotype-Phenotype Association. PLoS ONE. 10(11). e0142174–e0142174. 30 indexed citations
8.
Andrejević, Sladjana, et al.. (2013). Immunoserological parameters in SLE: high-avidity anti-dsDNA detected by ELISA are the most closely associated with the disease activity. Clinical Rheumatology. 32(11). 1619–1626. 43 indexed citations
9.
Matić, Ivana Z., Nađa Grozdanić, Ana Damjanović, et al.. (2012). Serum activity of DPPIV and its expression on lymphocytes in patients with melanoma and in people with vitiligo. BMC Immunology. 13(1). 48–48. 17 indexed citations
10.
11.
Popović, Dragan, et al.. (2011). Anti-neutrophil cytoplasmic antibodies (ANCA) specific for one or several antigens: useful markers for subtypes of ulcerative colitis and associated primary sclerosing cholangitis. Clinical Chemistry and Laboratory Medicine (CCLM). 50(3). 503–9. 12 indexed citations
12.
Bonači‐Nikolić, Branka, et al.. (2010). Prolonged infections associated with antineutrophil cytoplasmic antibodies specific to proteinase 3 and myeloperoxidase: diagnostic and therapeutic challenge. Clinical Rheumatology. 29(8). 893–904. 74 indexed citations
13.
Bonači‐Nikolić, Branka, et al.. (2007). Serological and Clinical Comparison of Children and Adults with Anti-Endomysial Antibodies. Journal of Clinical Immunology. 27(2). 163–171. 9 indexed citations
14.
Bonači‐Nikolić, Branka, et al.. (2006). Autoantibodies to Mitotic Apparatus: Association with Other Autoantibodies and Their Clinical Significance. Journal of Clinical Immunology. 26(5). 438–446. 23 indexed citations
15.
Andrejević, Sladjana, et al.. (2005). Anti-oxLDL antibodies--marker for arterial thromboses in antiphospholipid syndrome?. PubMed. 51(5-6). 279–83. 10 indexed citations
16.
Bonači‐Nikolić, Branka, et al.. (2005). Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides. Arthritis Research & Therapy. 7(5). R1072–81. 86 indexed citations
17.
Andrejević, Sladjana, et al.. (2003). Purpura and leg ulcers in a patient with cryoglobulinaemia, non-Hodgkin's lymphoma, and antiphospholipid syndrome. Clinical and Experimental Dermatology. 28(2). 151–153. 17 indexed citations
18.
Andrejević, Sladjana, Branka Bonači‐Nikolić, Djuro Μacut, et al.. (2002). Intracardiac thrombosis and fever possibly triggered by ovulation induction in a patient with antiphospholipid antibodies. Scandinavian Journal of Rheumatology. 31(4). 249–251. 16 indexed citations
19.
Ajtić, Olivera Mitrović, et al.. (1999). [The role of endothelial cells in allergic inflammation reactions].. PubMed. 126(3-4). 138–44. 3 indexed citations
20.
Andrejević, Sladjana, Mirjana Dimitrijević, Olgica Laban, et al.. (1997). Stress-Induced Rise in Serum Anti-Brain Autoantibody Levels in the Rat. International Journal of Neuroscience. 89(3-4). 153–164. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026